文献速递衰弱、肌少症与跌倒老年慢病共病管理

国际前瞻性注册研究:不同年龄NSTEMI患者的就诊特征、诊疗、冠脉介入与结局

Presentation, care, coronary intervention and outcomes of patients with NSTEMI according to age: insights from the international prospective ACVC-EAPCI EORP NSTEMI registry.
PubMed 文献 · Age Ageing · 2024-01-01

基于国际前瞻性ACVC-EAPCI EORP NSTEMI注册研究,纳入59国287中心2947例NSTEMI患者,按年龄分层(≥75岁n=761)。≥75岁患者合并症更多、口服抗凝比例更高,接受侵入性冠脉造影(ICA)更少,冠脉病变更重但血运重建更少,院内急性心衰、出血及院内和30天死亡率均更高。

要点

  • ≥75岁NSTEMI患者接受ICA的比例显著低于年轻患者(78.6% vs 90.6%,p<0.001)。
  • ≥75岁患者冠脉三支/四支和/或左主干病变比例更高(49.7% vs 34.1%,p<0.001),但血运重建更少(63.6% vs 76.9%,p<0.001)。
  • ≥75岁患者院内急性心衰(15.0% vs 8.4%)、出血(2.8% vs 1.3%)及院内和30天死亡率(3.4% vs 1.3%;4.8% vs 1.7%)均更高。

核心结论

  • ≥75岁NSTEMI患者较年轻患者更少接受ICA和指南推荐治疗,短期结局更差。

研究设计与样本

  • 国际前瞻性队列研究,纳入59国287中心2947例NSTEMI患者,按年龄分层(≥75岁n=761)。
  • 以12项指南推荐治疗措施评估照护质量,并收集ICA数据。

主要发现

  • ≥75岁患者合并症更多,口服抗凝处方比例更高(22.4% vs 7.6%,p<0.001)。
  • ≥75岁患者接受ICA更少(78.6% vs 90.6%,p<0.001),记录原因多为高龄、合并症或衰弱。
  • 接受ICA的≥75岁患者三支/四支和/或左主干病变更多(49.7% vs 34.1%,p<0.001),血运重建更少(63.6% vs 76.9%,p<0.001)。
  • ≥75岁患者院内急性心衰(15.0% vs 8.4%,p<0.001)和出血(2.8% vs 1.3%,p=0.006)更高。
  • ≥75岁患者院内死亡率(3.4% vs 1.3%,p<0.001)和30天死亡率(4.8% vs 1.7%,p<0.001)更高。

关键数值与推荐

  • 以12项指南推荐治疗措施评估照护质量。
  • 年龄分层界值为≥75岁。

临床怎么用

  • 对≥75岁NSTEMI患者应关注高龄、合并症和衰弱对ICA决策的影响,并评估指南推荐治疗的落实。
  • ≥75岁NSTEMI患者短期死亡、心衰和出血风险更高,临床需加强监测与风险管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Older people less frequently receive invasive coronary angiography (ICA) for NSTEMI than younger patients. We describe care, ICA data, and in-hospital and 30-day outcomes of NSTEMI by age in a contemporary and geographically diverse cohort. METHODS: Prospective cohort study including 2947 patients with NSTEMI from 287 centres in 59 countries, stratified by age (≥75 years, n = 761). Quality of care was evaluated based on 12 guideline-recommended care interventions, and data collected on ICA. Outcomes included in hospital acute heart failure, cardiogenic shock, repeat myocardial infarction, stroke/transient ischaemic attack, BARC Type ≥3 bleeding and death, as well as 30-day mortality. RESULTS: Patients aged ≥75 years, compared with younger patients, at presentation had a higher prevalence of comorbidities and oral anticoagulation prescription (22.4% vs 7.6%, p < 0.001). Older patients less frequently received ICA than younger patients (78.6% vs 90.6%, p < 0.001) with the recorded reason more often being advanced age, comorbidities or frailty. Of those who underwent ICA, older patients more frequently demonstrated 3-vessel, 4-vessel and/or left main stem coronary artery disease compared to younger patients (49.7% vs 34.1%, p < 0.001) but less frequently received revascularisation (63.6% vs 76.9%, p < 0.001). Older patients experienced higher rates of in-hospital acute heart failure (15.0% vs 8.4%, p < 0.001) and bleeding (2.8% vs 1.3%, p = 0.006), as well as in-hospital and 30-day mortality (3.4% vs 1.3%, p < 0.001; 4.8% vs 1.7%, p < 0.001; respectively), than younger patients. CONCLUSIONS: Patients aged ≥75 years with NSTEMI, compared with younger patients, less frequently received ICA and guideline-recommended care, and had worse short-term outcomes.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Nadarajah R, Ludman P, Laroche C, et al. Presentation, care, coronary intervention and outcomes of patients with NSTEMI according to age: insights from the international prospective ACVC-EAPCI EORP NSTEMI registry. Age Ageing. 2024. PMID: 39158485. doi:10.1093/ageing/afae179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。